MICHELLE RHYMESTINE: Open Payments
NPI 1659311157 · UTICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,608 in 114 payments from 18 companies in 2025. Trend: 2023 $2,178 · 2024 $1,856 · 2025 $2,608
Food & beverage: $2,547Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $650 |
| Janssen Biotech, Inc. | 27 | $601 |
| Madrigal Pharmaceuticals | 4 | $289 |
| Gilead Sciences, Inc. | 10 | $164 |
| Lilly USA, LLC | 9 | $143 |
| Aimmune Therapeutics, Inc. | 6 | $137 |
| PFIZER INC. | 8 | $136 |
| GENZYME CORPORATION | 4 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Intercept Pharmaceuticals, Inc. | 3 | $65 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, OMVOH, VELSIPITY, VOWST, XIFAXAN.
Industry payments across NY — which companies pay providers there.
